Janux Therapeutics (NASDAQ:JANX) Upgraded by Zacks Investment Research to Hold

Janux Therapeutics stock has undergone multiple analysts rating changes in the recent past.  Janux Therapeutics Upgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of Janux Therapeutics traded up $1.43 on Wednesday, reaching $21.48. 0 shares of the stock traded hands, compared to its average volume of 204995. Shares of Janux Therapeutics were trading at $21.48 on Wednesday. The firm’s 50 day moving average is $27.66 and its 200 day moving average is N/A.Janux Therapeutics has a 12 month low of $19.01 and a 12 month high of $37.99. While on yearly highs and lows, Janux Therapeutics’s today has traded high as $21.72 and has touched $19.01 on the downward trend. See More Analyst Rating at: RATING

Janux Therapeutics Earnings and What to expect: 

Janux Therapeutics last posted its earnings results on August 10th, 2021. The reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.48. The business had revenue of $0.48 million for the quarter. Janux Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Janux Therapeutics are expected to remain at ($1.00) per share in the coming year. Janux Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 9th, 2021 based off prior year’s report dates.

Earnings for Janux Therapeutics are expected to remain at ($1.00) per share in the coming year.

Janux Therapeutics (NASDAQ:JANX) Moving Average Technical Analysis

5 day Moving Average is $20.64 And 5 day price change is -$0.54 (-2.45%)  with average volume for 5 day average is 63,980. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $23.24 and 20 day price change is -$9.61 (-30.91%) and average 20 day moving volume is 217,300. 50 day moving average is $27.66  and 50 day price change is -$11.51 ( -34.89%)  and with average volume for 50 days is : 185,180. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Janux Therapeutics :

  • On 8/17/2021 shares held by Woodline Partners LP were 334,260 which equates to market value of $8.34M and appx 0.20% owners of Janux Therapeutics
  • On 8/17/2021 shares held by Samsara BioCapital LLC were 607,949 which equates to market value of $15.17M and appx 1.90% owners of Janux Therapeutics
  • On 8/17/2021 shares held by Logos Global Management LP were 547,122 which equates to market value of $13.65M and appx 1.20% owners of Janux Therapeutics
  • In total Institutional ownership equates to Institutional Ownership Percentage: 59.46% for Janux Therapeutics

See More Analyst Rating at: RATING